Galvanised by the US, thirteen of the EU's major trading partners
have called for a reconsideration of the EU's draft chemicals
legislation, calling it "potentially disruptive" to world
trade.
In the company's largest investment of its kind in Asia,
GlaxoSmithKline (GSK) has decided to build a new vaccine
manufacturing plant in Singapore, as several products in its
pipeline approach commercialisation.
The Cambrex Corporation and Cytori Therapeutics have formed a
collaboration that aims to provide adipose-derived stem cell
products globally for use in basic and translational bioresearch.
Tripos has announced the release of the latest version of its
visualisation platform that allows laboratory scientists to make
better informed decisions based on the three-dimensional molecular
information it produces.
Medical technology company e-pill has unveiled a new automated pill
dispenser which delivers medications at the right time and in the
right amount, ensuring compliance.
Liquid handling specialists Anachem has made available a recycling
programme for the waste polypropylene racks produced by its new
range of high quality robotic tips designed to fit Tecan, Qiagen,
Beckman or Gilson Robotic Platforms.
Invitrogen has formed a collaboration to supply reagents for
Solexa's Genome Analysis System, a sequencing technology that has
the potential to generate over a billion bases of DNA sequence data
per run.
After receiving a grant of $3.9m (€3m) from the US government,
British biotechnology firm Avecia has put together a consortium of
four companies to develop a version of its anthrax vaccine with
increased stability so it works without...
UK firm Domino Printing Sciences has launched a new data print
solution that will allow the late stage customisation of printing
on pharmaceutical packages.
While praising the benefits of radio-frequency identification
(RFID), the US Food and Drug Administration (FDA) has refrained
from demanding its implementation in new measures it unveiled to
combat counterfeit drugs, asking instead...
BioMedica Diagnostic is to open a manufacturing facility in Ghana
that will produce affordable laboratory equipment whilst meeting
the need for a home grown African diagnostic solution for the
Continent's medical problems.
US biotechnology firm Bio-Bridge Science, whose ambition is to
develop an HIV vaccine, has finished major construction of a good
manufacturing practice (GMP) research and manufacturing facility in
Beijing.
TAGSYS have developed two new item-level radio frequency
identification (RFID) readers that it claims will improve
pharmaceutical inventory management.
Outsourcing-Pharma.com focus on: cutting the cost of clinical trials
Outsourcing-Pharma.com sheds some light on how pharma companies can
make sure they are choosing a contract research organisations (CRO)
that will stick to the rules of ethics when running clinical trials
in poorly-regulated countries...
eClinical software and services firm etrials has launched the
latest version of its eDiary technology, which the company claims
will lead to cost savings and increased efficiency in the clinical
trial process.
Biotechnology firm Invitrogen has opened a new facility in New York
which can make its Advanced Granulation Technology (AGT) media
totally free of animal origin components while addressing key
bottlenecks in drug production.
Invitrogen has announced the opening of a new research facility to
be located in Scotland. The decision adds to the investment influx
within the region, which has seen 20 per cent of the UK's biotech
companies set up research...
Pall is organising a free chromatography seminar in Paris this week
presented by leading chromatographers from the pharmaceutical,
biotechnology and biologicals industries.
PerkinElmer has launched a new antibody-free kinase assay
technology that is set to play a major role in drug discovery by
allowing researchers to perform direct measurements of kinase
activities on full-length protein substrates...
Velocity11 has made available globally, a gripper accessory for its
Bravo Liquid Handling Platform that enables a broader range of
fully automated applications to be achieved by the compact Bravo
platform.
Drug delivery firm Egalet has asked SP Medical, a manufacturer of
moulded plastics and coatings, to make sufficient clinical grade
quantities of its therapeutics using injection moulding, which
allows for greater uniformity and reproducibility...
A study that has uncovered core functional differences between a
new oestrogen receptor could form the basis of novel and
potentially more effective treatments of breast cancer as
researchers sought to utilise this therapeutic target.
A membrane protein factory, which represents over half of all known
drug targets could lead to new and improved pharmaceutical
treatments for a broad range of illnesses such as depression, heart
disease, addictions and cystic fibrosis.
Nastech has secured a contract with Procter & Gamble (P&G)
to ramp up manufacturing capacity for a new needle-free drug to
beat osteoporosis, in anticipation of meeting expected global
demand once the product is approved.
Applied Biosystems (AB) make available a wider range of microRNA
assays, expanding the selection to 300 individual assays that are
ideal for cell differentiation, developmental biology, stem cell
and cancer research.
Scientists believe they have made a breakthrough in the fight
against HIV drug resistance by developing a drug that is the first
in a new class of HIV drug candidates called Maturation Inhibitors.
Medical innovations company BTG, continued its progress on the
strategy it implemented last May by revealing its operating
highlights that has seen six new programmes added to its product
pipeline.
AstraZeneca sought to reassure investors this week by providing an
update on progress made in strengthening its product pipeline, a
worry for industry analysts who believe its existing products
cannot underpin earnings growth for...
Contract research company, EpiStem have announced the successful
installation of an automated imaging system that now enables the
firm to expand the range and throughput of its services in
immunohistochemistry (IHC) and histometric...
A new one-step test that is designed to distinguish
heterophile-positive, infectious mononucleosis (IM) from other
common symptomatic infections, claims to deliver a 99 per cent
sensitivity score, significantly improving on current...
After recently opening up shop in nearby Singapore, SGS has now
brought its contract testing services to neighbouring China to
continue to cash in on the demand for such services in the
Asia-Pacific region.
Werum Software & Systems has updated its manufacturing
execution systems (MES) for the pharmaceutical and
biopharmaceutical industry, enhancing process reliability and cost
effectiveness.
SurModics has licensed its advanced hydrophilic coating technology
to Xtent for use in the delivery system of its novel drug-eluting
stent (DES) system, designed to reduce the time, complexity and
cost of coronary stent procedures.
Determined to reduce costs in its manufacturing operations,
Schering-Plough has announced the loss of 1,100 positions in
manufacturing sites in Puerto Rico and New Jersey, aiming to save
$100m (€78.1m) a year.
Jacobs Engineering Group has been chosen to upgrade and expand
GlaxoSmithKline's (GSK) manufacturing capability at its Irish
plant, as well as develop a new biological manufacturing facility
for US firm Northfield Laboratories.
Outsourcing-Pharma.com focus on: cutting the cost of clinical trials
Outsourcing-Pharma takes a look at how clinical research
organisations (CROs) operating in India can do their best to ensure
that clinical trials in the region are carried out ethically.
Biotechnology firm Gilead has acquired Raylo Chemicals, a Canadian
production unit of active pharmaceutical ingredients (APIs) and
advanced intermediates, from Degussa for €115m, seeking to bring
more manufacturing capacity and expertise...
Fine chemicals company Hovione has passed an inspection by the US
Food and Drug Administration (FDA) at its active pharmaceutical
ingredient (API) manufacturing site in Loures, Portugal, as it
tries to conform with ever-stricter standards.
Following a charm offensive by several US states, Bristol-Myers
Squibb (BMS) has selected Devens, Massachusetts to build a
significant manufacturing facility for several of its biologic
drugs, ending months of speculation about the...
Looking to add active pharmaceutical ingredients (APIs) and
intermediates to its Chinese portfolio, Degussa has acquired a
majority stake in the Chinese fine chemicals firm Lynchem, allowing
it to target the pharma industry more competitively.
Pharmaceutical companies looking to eliminate manual handling of
samples to enhance productivity may want to look at Genevac's new
automated centrifugal evaporators.
PowerMed has demonstrated the immunogenicity of an influenza DNA
vaccine for the first time in humans using a new drug delivery
system and claims it may serve as a cost-effective weapon against
bird flu.
UK novel drug delivery developer Vectura and UK venture capital
firm Unilever Ventures have jointly established a new speciality
pharmaceutical company focusing on oral and transdermal drug
delivery systems.
A new class of drug that targets breast cancer by blocking
production of oestrogen and reducing serious side effects for many
more, could eventually become the gold-standard for cancer
treatment.
Medical innovations firm BTG reported a full year pre-tax profit,
driven by growing recurring revenues and litigation settlements
that threatened to dissolve into a long running legal dispute.
New research has suggested that that pharmacological inhibition of
a protein's role in Alzheimer's, Parkinson's and cancer research
could be key to either preventing or promoting cell death.
Major drug companies across the US are in process of reformulating
their over-the-counter cold medications in time for a new law that
comes in to effect later this year restricting the sale of drugs
that contain pseudoephedrine.
Bioxel, a company which manufactures and markets taxane active
pharmaceutical ingredients (APIs) used in chemotherapeutic drugs,
has turned to two contract manufacturing companies to scale up
production.
Outsourcing-Pharma focus: cutting the cost of clinical trials
After recent allegations in the media that poor and illiterate
patients in India are being used, often unknowingly, as human
guinea pigs to test new drugs for the pharma giants of the West,
Outsourcing-Pharma takes a look at how cutting...
